Glypican-1 in rhabdomyosarcoma: a multi-omics exploration of a targetable biomarker
Al-zu'bi B, Jaradat JH, et al.
Current Cancer Drug Targets
Comprehensive multi-omics profiling identifying Glypican-1 as a candidate therapeutic vulnerability in paediatric and adult rhabdomyosarcoma.
Multi-Omics · Targetable Biomarker · Sarcoma